Zeynep Eroglu

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Topics

Basal Cell Carcinoma

Top Venues

Journal for immunotherapy of cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Joseph Markowitz, Michael Shamblott, Andrew S Brohl, Amod A Sarnaik, Zeynep Eroglu, Nikhil I Khushalani, Christopher W Dukes, Alejandra Chamizo, Marina Bastawrous, Edward T Garcia, Ashraf Dehlawi, Pei-Ling Chen, Deanryan B De Aquino, Vernon K Sondak, Ahmad A Tarhini, Youngchul Kim, Patricia Lawman, Shari A Pilon-Thomas
First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0. Molecular cancer therapeutics 23 (8) (2024)
Kara M Schenk, Julie Stein Deutsch, Sunandana Chandra, Diwakar Davar, Zeynep Eroglu, Nikhil I Khushalani, Jason John Luke, Patrick A Ott, Jeffrey A Sosman, Vikram Aggarwal, Megan D Schollenberger, William H Sharfman, Kristin P Bibee, Jeffrey F Scott, Manisha J Loss, Hao Wang, Hanfei Qi, Elad Sharon, Howard Streicher, Helen X Chen, Robert N Woodward, Serena M Bagnasco, Janis M Taube, Suzanne L Topalian, Daniel C Brennan, Evan J Lipson
Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous Cancers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Joseph Markowitz, Michael Shamblott, Andrew S Brohl, Amod A Sarnaik, Zeynep Eroglu, Nikhil I Khushalani, Christopher W Dukes, Alejandra Chamizo, Marina Bastawrous, Edward T Garcia, Ashraf Dehlawi, Pei-Ling Chen, Deanryan B De Aquino, Vernon K Sondak, Ahmad A Tarhini, Youngchul Kim, Patricia Lawman, Shari A Pilon-Thomas
First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0. Molecular cancer therapeutics 23 (8) (2024)
Tanya Ramadoss, Matthew Nichols, Christian Palacios, Zeynep Eroglu, Joseph Markowitz, Lilit Karapetyan, Ahmad A Tarhini, Evan J Wuthrick, Vernon K Sondak, Nikhil I Khushalani, Kenneth Y Tsai, Andrew S Brohl
Durability of response to immune checkpoint blockade following treatment discontinuation and efficacy of rechallenge in advanced Merkel cell carcinoma. Journal for immunotherapy of cancer 12 (9) (2024)
Kara M Schenk, Julie Stein Deutsch, Sunandana Chandra, Diwakar Davar, Zeynep Eroglu, Nikhil I Khushalani, Jason John Luke, Patrick A Ott, Jeffrey A Sosman, Vikram Aggarwal, Megan D Schollenberger, William H Sharfman, Kristin P Bibee, Jeffrey F Scott, Manisha J Loss, Hao Wang, Hanfei Qi, Elad Sharon, Howard Streicher, Helen X Chen, Robert N Woodward, Serena M Bagnasco, Janis M Taube, Suzanne L Topalian, Daniel C Brennan, Evan J Lipson
Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous Cancers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Kara M Schenk, Julie Stein Deutsch, Sunandana Chandra, Diwakar Davar, Zeynep Eroglu, Nikhil I Khushalani, Jason John Luke, Patrick A Ott, Jeffrey A Sosman, Vikram Aggarwal, Megan D Schollenberger, William H Sharfman, Kristin P Bibee, Jeffrey F Scott, Manisha J Loss, Hao Wang, Hanfei Qi, Elad Sharon, Howard Streicher, Helen X Chen, Robert N Woodward, Serena M Bagnasco, Janis M Taube, Suzanne L Topalian, Daniel C Brennan, Evan J Lipson
Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous Cancers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Joseph Markowitz, Michael Shamblott, Andrew S Brohl, Amod A Sarnaik, Zeynep Eroglu, Nikhil I Khushalani, Christopher W Dukes, Alejandra Chamizo, Marina Bastawrous, Edward T Garcia, Ashraf Dehlawi, Pei-Ling Chen, Deanryan B De Aquino, Vernon K Sondak, Ahmad A Tarhini, Youngchul Kim, Patricia Lawman, Shari A Pilon-Thomas
First-in-human stage III/IV melanoma clinical trial of immune priming agent IFx-Hu2.0. Molecular cancer therapeutics (2024)
Joseph Markowitz, Michael Shamblott, Andrew S Brohl, Amod A Sarnaik, Zeynep Eroglu, Nikhil I Khushalani, Christopher W Dukes, Alejandra Chamizo, Marina Bastawrous, Edward T Garcia, Ashraf Dehlawi, Pei-Ling Chen, Deanryan B De Aquino, Vernon K Sondak, Ahmad A Tarhini, Youngchul Kim, Patricia Lawman, Shari A Pilon-Thomas
First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0. Molecular cancer therapeutics 23 (8) (2024)
Prachi Bhave, Angela Hong, Serigne N Lô, Rebecca Johnson, Johanna Mangana, Douglas B Johnson, Ozgecan Dulgar, Zeynep Eroglu, Hui-Ling Yeoh, Andrew Haydon, Georg C Lodde, Elisabeth Livingstone, Adnan Khattak, Katharina Kähler, Axel Hausschild, Grant A McArthur, Alexander Maxwell Menzies, Georgina Long, Wei Wang, Matteo S Carlino
Efficacy and toxicity of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy. Journal for immunotherapy of cancer 11 (3) (2023)
Zeynep Eroglu, Y Ann Chen, Inna Smalley, Jiannong Li, Joseph K Markowitz, Andrew S Brohl, Leticia Tetteh, Hayley Taylor, Vernon K Sondak, Nikhil I Khushalani, Keiran S M Smalley
Combined BRAF, MEK, and heat-shock protein 90 (HSP90) inhibition in advanced BRAF V600-mutant melanoma. Cancer (2023)
Prachi Bhave, Angela Hong, Serigne N Lô, Rebecca Johnson, Johanna Mangana, Douglas B Johnson, Ozgecan Dulgar, Zeynep Eroglu, Hui-Ling Yeoh, Andrew Haydon, Georg C Lodde, Elisabeth Livingstone, Adnan Khattak, Katharina Kähler, Axel Hausschild, Grant A McArthur, Alexander Maxwell Menzies, Georgina Long, Wei Wang, Matteo S Carlino
Efficacy and toxicity of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy. Journal for immunotherapy of cancer 11 (3) (2023)
Prachi Bhave, Angela Hong, Serigne N Lô, Rebecca Johnson, Johanna Mangana, Douglas B Johnson, Ozgecan Dulgar, Zeynep Eroglu, Hui-Ling Yeoh, Andrew Haydon, Georg C Lodde, Elisabeth Livingstone, Adnan Khattak, Katharina Kähler, Axel Hausschild, Grant A McArthur, Alexander Maxwell Menzies, Georgina Long, Wei Wang, Matteo S Carlino
Efficacy and toxicity of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy. Journal for immunotherapy of cancer 11 (3) (2023)
Zeynep Eroglu, Shifra Krinshpun, Ekaterina Kalashnikova, Sumedha Sudhaman, Turkan Ozturk Topcu, Matt Nichols, Justin Martin, Katherine M Bui, Charuta C Palsuledesai, Meenakshi Malhotra, Perry Olshan, Joseph Markowitz, Nikhil I Khushalani, Ahmad A Tarhini, Jane L Messina, Alexey Aleshin
Circulating tumor DNA-based molecular residual disease detection for treatment monitoring in advanced melanoma patients. Cancer (2023)
Prachi Bhave, Angela Hong, Serigne N Lô, Rebecca Johnson, Johanna Mangana, Douglas B Johnson, Ozgecan Dulgar, Zeynep Eroglu, Hui-Ling Yeoh, Andrew Haydon, Georg C Lodde, Elisabeth Livingstone, Adnan Khattak, Katharina Kähler, Axel Hausschild, Grant A McArthur, Alexander Maxwell Menzies, Georgina Long, Wei Wang, Matteo S Carlino
Efficacy and toxicity of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy. Journal for immunotherapy of cancer 11 (3) (2023)
Ann W Silk, Christopher A Barker, Shailender Bhatia, Kathryn B Bollin, Sunandana Chandra, Zeynep Eroglu, Brian R Gastman, Kari L Kendra, Harriet Kluger, Evan J Lipson, Kathleen Madden, David Michael Miller, Paul T Nghiem, Anna C Pavlick, Igor Puzanov, Guilherme Rabinowits, Emily S Ruiz, Vernon K Sondak, Edward A Tavss, Michael T Tetzlaff, Isaac Brownell
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer. Journal for immunotherapy of cancer 10 (7) (2022)
Nikhil I Khushalani, Melinda Vassallo, Judith D Goldberg, Zeynep Eroglu, Younchul Kim, Biwei Cao, Robert Ferguson, Kelsey R Monson, Tomas Kirchhoff, Carol M Amato, Paulo Burke, Ann Strange, Emily Monk, Geoffrey Thomas Gibney, Ragini Kudchadkar, Joseph Markowitz, Andrew S Brohl, Anna Pavlick, Alison Richards, David M Woods, Jeffrey S Weber
Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma. Journal for immunotherapy of cancer 10 (11) (2022)
Zeynep Eroglu, Kristy K Broman, John F Thompson, Amanda Nijhuis, Tina J Hieken, Lisa Kottschade, Jeffrey M Farma, Meghan Hotz, Jeremiah Deneve, Martin Fleming, Madalyn G Neuwirth, Avinash Sharma, Lesly Dossett, Tasha Hughes, David E Gyorki, Jennifer Downs, Giorgos Karakousis, Yun Song, Ann Lee, Russell S Berman, Alexander van Akkooi, Emma Stahlie, Dale Han, John Vetto, Georgia M Beasley, Norma E Farrow, Jane Yuet Ching Hui, Marc Moncrieff, Jenny Nobes, Kirsten Baecher, Matthew Perez, Michael C Lowe, David W Ollila, Frances A Collichio, Roger Olofsson Bagge, Jan Mattsson, Hidde M Kroon, Harvey Chai, Jyri Teras, James Sun, Michael J Carr, Ankita Tandon, Nalan Akgul Babacan, Younchul Kim, Mahrukh Naqvi, Jonathan Zager, Nikhil I Khushalani
Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection. Journal for immunotherapy of cancer 10 (8) (2022)
Daniel J Olson, Zeynep Eroglu, Bruce E Brockstein, Andrew S Poklepovic, Madhuri Bajaj, Sunil Babu, Sigrun Hallmeyer, Mario Velasco, Jose Lutzky, Emily F Higgs, Riyue Bao, Timothy Clifford Carll, Brian Labadie, Thomas Krausz, Yuanyuan Zha, Theodore Karrison, Vernon K Sondak, Thomas F Gajewski, Nikhil I Khushalani, Jason John Luke
Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (24) (2021)
Isabella C Glitza Oliva, Keiran S M Smalley, Priscilla K Brastianos, Michael A Davies, Ian McCutcheon, James K C Liu, Kamran A Ahmed, John A Arrington, Brittany R Evernden, Inna Smalley, Zeynep Eroglu, Nikhil Khushalani, Kim Margolin, Harriet Kluger, Michael B Atkins, Hussein Tawbi, Adrienne Boire, Peter A Forsyth
Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directions. Pigment cell & melanoma research 33 (4) (2020)
Zeynep Eroglu, Jennifer Eatrides, Syeda Mahrukh Hussnain Naqvi, Youngchul Kim, Jeani Rich, Nalan Akgul Babacan, Andrew S Brohl, Joseph Markowitz, Amod Sarnaik, Jonathan Zager, Nikhil I Khushalani, Vernon K Sondak, Jane Messina
Neoadjuvant BRAF-targeted therapy in regionally advanced and oligometastatic melanoma. Pigment cell & melanoma research 33 (1) (2019)